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Abstract

Caseous lymphadenitis (CL) is a chronic disease that affects sheep and goats
worldwide. CL causes a large economic loss to producers via milk and fiber losses,
carcass

condemnation,

and

chronic

wasting

of

animals.

Corynebacterium

pseudotuberculosis (C. psTB) causes CL, and infected animals produce abscesses,
typically in lymph nodes, lungs, liver, and mammary tissues. Ruptured abscesses release
C. psTB, and can contaminate the environment. The bacteria are extremely hardy and can
survive in the external environment for over a year, infecting other animals through open
wounds.

Macrophages engulf C. psTB when it enters the body, and carry it to the lymph nodes.
Corynebacterium pseudotuberculosis possesses some mechanisms that prevent lysis by
the macrophages. When C. psTB reaches the lymph tissues, many immune cells attack the
area, and this causes the abscesses. Recent studies suggest that some individual animals
are resistant to clinical CL. To test this phenomenon, we collected blood from cattle and
sheep, developed a protocol for macrophage culture, and produced CL antigens to
challenge the macrophages. We tested macrophage cytokine (IL10) response to
stimulation with antigens using a commercial Enzyme Linked Immunosorbent Assay
(ELISA). There was no measureable IL10 response detected. Future work will evaluate
other cytokines (IL8) and will investigate genetic (NOD2) resistance to CL.
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Introduction

Sheep producers have a substantial impact on the farm economy, but factors like
predation and disease seriously affect their business. In the United States, there are over
5.2 million sheep. The gross income from the sheep industry in the United Sates is 5.5
million dollars per year. In New England (Maine, Massachusetts, Vermont, New
Hampshire, Rhode Island, and Connecticut) alone, there are 43,000 sheep and lambs.1
In 2009, 387,300 sheep and lambs lost in the United States (61% of total losses) were
due to non-predatory factors, and of these, almost 30% were disease-related.2 These
losses cause an economic impact on the producers who raise sheep in the United States.
In 2003, a report from Australia claimed that caseous lymphadenitis (CL) causes a 4-7%
decrease in clean wool production per sheep, per year.3 Along with carcass condemnation
due to abscesses, this disease causes a significant impact to small ruminant producers. If a
farmer had 200 sheep with CL, and they lost 5% of wool production and 10% of
carcasses, they would lose close to $500 per year. This is potentially a bigger factor with
chronic diseases, like CL, which cause economic losses year after year because
chronically infected animals remain part of the flock.
Caseous lymphadenitis is a chronic disease caused by Corynebacterium
pseudotuberculosis (C. psTB) that affects a number of species, including small ruminants.
Caseous lymphadenitis causes internal and external abscesses, typically of the lymph
nodes, but also of internal organs, including the liver, mammary tissue, and lungs. Once
this disease affects one animal in the flock, it is nearly impossible to remove from the
flock. Most farms ‘manage’ a flock with CL, rather than eradicate the disease.4 There are
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two main methods of handling flocks with CL. The first is the “Test and Cull” method. In
this program, farmers test all of the animals in their flock or herd, and cull any that come
up positive for the CL antibodies. The farmer waits two months, and tests all of the
animals again, and culls any positive. This continues until the farmer no longer has any
animals that are positive for CL antibodies. This method is an effective way to rid a farm
of CL, but it is difficult to maintain flock size, let alone grow a flock, and it also can cost
the producer a lot of money in lost products.5
The second management strategy is to keep two separate flocks. One flock is CLpositive animals, and one flock is CL-negative animals. If a farmer has animals they do
not want to cull, this method can be effective. The downfall with this is that it is
expensive because the two flocks must have completely separate land, shelters, feeders,
and equipment, and there cannot be any overlap. It is also inconvenient to take care of
two distinct flocks, and a farmer must always work with the CL-negative flock first, and
then move to the CL-positive flock. Over time, it is possible to remove CL from a farm
using this manner. Any lambs that are born in the CL-positive flock need to be pulled
immediately and hand-reared or adopted to an animal in the CL-negative flock.
Eventually, the animals in the CL-positive flock will be removed by natural attrition
(natural death or culling due to reduced productivity), and the farmer will be left with a
CL free farm. Both of these management strategies have disadvantages, but keeping
infected animals in contact with non-infected animals will cause a continual economic
loss to the producer.6
Caseous lymphadenitis is most frequently characterized by the formation of external
abscesses on the superficial lymph nodes of the animals. The disease does not always
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present visible abscesses, and because of this, it is difficult to detect the prevalence of
CL.7 In 2003, a study in Australia found that 26% of sampled farms had animals with
CL.8 There has been an estimated prevalence of up to 43% in the United States.9 This
disease presents not only an economic challenge, but because CL is also a zoonotic
disease, which means it poses a threat for humans who work with infected animals, it can
become a public health challenge.10
How is CL spread? The bacteria’s main path of entry into the host is through a cut or
abrasion in the skin. Shearing equipment often acts as a tool for passing the bacteria from
one animal to another. CL causes abscesses in the lymph nodes and some internal organs.
When a CL abscess bursts, a “cheesy” (caseous) pus, containing millions of C. psTB, is
released, and can survive in the external environment and infect other animals for
months. Thus, CL is a persistent threat once established on a farm.
Once in the host, how does CL cause damage? The bacteria are ill equipped to set up
an infection at the site of entry, so most often, the abscesses do not appear at the site of
the external wound. Instead, a macrophage phagocytizes the bacterium, and carries it to
the lymph nodes. Normally, invading bacteria are killed in the macrophage by the
lysosome. However, because these bacteria are facultative intracellular pathogens, they
can survive in the macrophage for up to 48 hours.11 The bacteria contain an external lipid
layer of the cell wall, which allows them to survive the action of phagolysosome
enzymes.12 Corynebacterium pseudotuberculosis produces phospholipase D (PLD), an
exotoxin that has been identified as the primary virulence factor of the bacteria. Most
researchers agree that the PLD is what is responsible for the ability of the bacteria to lyse
macrophages, and gain access to the lymph nodes.13
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When the bacteria infect the lymph nodes, many macrophages and lymphocytes rush
to the site of infection. These cells, led by macrophages, induce a thick wall of fibroblasts
and macrophages around the infection, creating a pyogranuloma.14 The external abscesses
may also include signs such as swelling and loss of hair at the area.15 Abscesses are the
primary sign of CL infection, and may be internal, so unseen by the farmer until
slaughter.
Host immune defenses are critical to avoiding CL. The immune system is broken into
innate and adaptive immunity. Innate immunity is non-specific, and acts as a defense
against any foreign body trying to enter the system. Adaptive immunity is responsible for
fighting against specific pathogens. Macrophages are considered cells in the category of
innate immunity, but they also act as the bridge between innate and adaptive immunity.
These cells phagocytize and digest foreign particles, which make them non-specific (like
the innate immune system), but they present antigens so that lymphocytes can create
antibodies, which then triggers the adaptive immune system. Macrophages also link the
innate and adaptive immune processes, by eliciting cytokine responses. Cytokines are
small proteins that act as “cell signals” in response to stimuli. Macrophages can
communicate to other macrophages, as well as with different cells using cytokines.16
Usually when a macrophage encounters a bacterium such as C. psTB, the macrophage
engulfs the bacterium, and immediately floods the bacteria with oxygen radicals and acid
in attempts to kill the cell.17 However, C. psTB can survive in the macrophages, and they
are carried to the lymph nodes inside the macrophages.18
The fact that C. psTB transits to the lymph nodes in macrophages suggests a possible
deficiency of macrophage function in animals with CL. Pépin et al. (1997) performed an
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experiment on lambs to evaluate cytokine release after infection with C. psTB. The
researchers inoculated the lambs with one of the following: C. psTB PLD toxin, a strain
of C. psTB lacking the PLD gene, a wild-type strain of C. psTB, or a control. After 7 or
28 days, they completed necropsies on the lambs, sampled the lymph nodes and lungs,
and performed polymerase chain reaction (PCR) on each sample, looking for production
of specific cytokines, including IL2, IL4, IL6, IL8, TNFα, and IFNγ. The study
concluded that there was a large amount of variability in the results, probably due to
individual variations among lambs. Interferon-γ appeared to be the most relevant
cytokine, as there was significant production of interferon- γ in all of the sheep infected
with any strain of the C. psTB bacteria.19
Recently, scientists have been using this information to try to create a simpler
diagnostic test for CL. Rebouças et al. (2011) collected peripheral blood leukocytes from
animals who tested seropositive for CL and animals who tested seronegative for CL.
Seropositive animals produced a higher amount of interferon-γ than seronegative
animals. They concluded this could be used a potential marker for animals with CL,
although the ELISA they created had a low sensitivity (55.8% and 56% in sheep and
goats, respectively), and the researchers suggested this value should be higher before this
is a complete diagnostic tool.20 Corynebacterium pseudotuberculosis is not the only
pathogen or condition that elicits release of IFNγ. This ELISA would most likely have
many false positives because of this fact.
Bastos et al. (2011) also outlined a possible diagnostic marker for CL. This study
focused on measuring the concentration of haptoglobin (a protein that binds to free
hemoglobin in the blood) and the total leukocyte count. The researchers concluded that
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the amount of haptoglobin and total leukocytes are not reliable markers for diagnosing
CL, however, the number of monocytes may be a consistent measurable value to
determine if an animals has CL.21 As of right now, the most reliable test is the Synergistic
Hemolytic Inhibition (SHI) test. Only a few laboratories in the nation complete this test.
A culture plate is created using 7% bovine blood and Rhodococcus equi toxin.
Corynebacterium pseudotuberculosis and R. equi will experience synergistic hemolysis
(or breaking down of red blood cells) when allowed to interact with one another. The SHI
test uses this fact to determine whether an animal has been exposed to CL or not. A blood
sample is taken from the animal, and sera is collected. On a small paper disk, CL toxin
and the sera are mixed. If the animal has been exposed to CL, their sera with contain CL
antibodies, the two toxins will not interact, and there will be no zone of clearing around
the disk. If an animal has never been exposed to CL, the two toxins will interact, and
there will be a zone of clearing around the disk.22
Interferon-γ can activate ovine pulmonary alveolar macrophages (PAM), along with
having many other functions. A second study investigated the roles of interferon-γ, tumor
necrosis factor α, and interleukin 1 levels in response to C. psTB in vitro using
macrophages collected post-mortem. Based on previous studies, the researchers
investigated whether cytokine production had an effect on the replication of C. psTB.
This study found that recombinant cytokines had no stimulatory or inhibitory effect on
the growth of the bacteria in an acellular system, however, the PAM significantly reduce
the growth of C. psTB. When the PAM were pretreated with cytokine, either one cytokine
at a time, or as combinations of more than one cytokine, there was no increase in
intracellular killing. Although macrophages reduced growth by phagocytizing these
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bacteria, macrophages were not effective at killing C. psTB once it was phagocytized.
This study did not report whether the macrophages were destroyed or intact following
infection with bacteria.23 This study suggests that these three cytokines (IFNγ, TNFα, and
IL1) do not have a stimulatory effect on the macrophages to enhance kill of C. psTB.
Although cytokine enhancement of CL-infected macrophage activity has been
investigated, cytokine suppression of macrophage activity may be a factor in CL
intracellular survival. These studies discussed demonstrate the need for further
investigation of how C. psTB interacts with macrophages, and why the macrophages do
not kill the bacteria upon phagocytosis.
Interleukin 10 (IL10) is a cytokine responsible for suppression of monocyte,
macrophage, T cell, and natural killer cell function. Specifically, IL10 inhibits the
transcription of other cytokines that these cells produce. Monocytes are the predominant
producers of IL10.24 For this reason, we chose to investigate if monocytes and
macrophages of animals that are CL-positive produce a different amount of IL10 than
cells of CL-negative animals.
The overall objective of this project is to investigate cytokines produced by CLpositive sheep’s macrophages, versus CL-negative sheep’s macrophages. The objectives
of this experiment were to develop procedures and techniques, such as effective blood
draw and collection skills, macrophage cell culturing methods, and proper use of an
Enzyme-Linked Immunosorbant Assay (ELISA) for investigation of macrophage
cytokine production.
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MATERIALS AND METHODS

Many small preliminary experiments were completed during this project. The first
experiment included drawing blood from seven sheep on a farm in Maine. Ten milliliters
of blood was drawn from the jugular vein of the animals into purple-topped vacutainers,
which contain the anticoagulant ethylenediamine tetraacetic acid (EDTA). This farm had
been previously tested, and was known to have CL-positive animals. Blood was drawn
from four older ewes (3+ years) that had repeatedly tested negative for CL antigens, one
female lamb (3 months old), whose CL status was unknown, and two CL+ rams. The
blood was processed in an initial attempt to isolate macrophages. A 2:1 solution was
made of Hank’s Balanced Salt Solution (HBSS) (Fisher Scientific, SH 3001602) and the
10mL of blood from each sheep. The mixture was then gently pipetted on top of a Ficoll
Paque (Fisher, 45-001-751) layer, and centrifuged to create layers of separation. The
layer just above the pellet of red blood cells that was thought to be the peripheral blood
mononuclear cells (PBMCs) was carefully pipetted off the Ficoll layer, using sterile
technique, and placed in a centrifuge tube with HBSS. The cells were washed using
gentle centrifugation (900xg for 30 minutes), and they were then resuspended in Roswell
Park Memorial Institute media with L-glutamine (RPMI) (Fisher, SH3002701) with
penicillin and streptomycin (pen/strep) (Fisher, BP295950), and 10% heat inactivated
fetal bovine serum (FBS) (Fisher, SH3091002HI). The suspension was then divided into
6 aliquots, and each was pipetted into a row of a 48-well plate. The plate was incubated
in a 35°C incubator at 5% CO2. During the incubation period, the cells were visually
inspected using an Olympus CKX41 inverted microscope. Changes in the density of
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cells, color of media, shape of cells, amount of contamination, and any other changes
were recorded. The media of these wells was freshened approximately every 7 days. The
old media was gently pipetted out of the wells and disposed of. One mL of HBSS was
added to each well, and the plate was rocked gently by hand for 1 minute to rinse the
cells. The HBSS was pipetted out of the wells, 1 mL of fresh supplemented RPMI was
placed back into the wells, and the plate was placed back in the CO2 incubator.
One month after processing this round of blood, the viability of the cultured cells was
determined. The cells were dislodged from their adherence to the plate by adding 0.05%
trypsin (Fisher, MT-25-051-CI). The cells were suspended in trypsin for 20 minutes, and
then a 50µL aliquot was taken from a well and added to a 1.5mL cryogenic tube, which
contained 175µL of supplemented RPMI and 25µL of 0.4% trypan blue (Fisher, MT-25900-Cl). This solution was mixed by gentle inversion of the tube, and 10µL were pipetted
onto the surface of a hemocytometer. A cover slip was applied, the number of cells in the
central grid was counted, and the cell concentration and viability was calculated based on
the area of the central grid (See Table 1). The cell count/mL was calculated using the Cell
Counting SOP. To find cells/mL blood, the number of cells seen in central grid was
multiplied by 104, which is the hemocytometer factor, and by the dilution factor. The
number of viable cells was determined using trypan blue, an impermeable dye. Live cells
will not take up this dye, but dead cells are permeable to it, and become stained blue.25
Each cell in the grid is counted, and the percent of viable cells is figured out by dividing
the number of unstained cells by the total number of cells in the grid.
In order to preserve these cell samples, a cell freezing technique was produced. The
cells were incubated in 1mL of 0.05% trypsin to remove them from the cell culture plate.
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The cells were placed in a 1.5mL cryogenic vial once they were no longer adherent to the
plate. The samples were centrifuged and the supernatant was removed. The pellets were
suspended in freezing media (RPMI with dimethyl sulfoxide; DMSO (Fisher, MT-25950-CQC)). Once resuspended, the cells were placed in a -20°C freezer for one hour, and
then transferred to an -80°C freezer for storage.
The next experiment involved taking blood from heifers at the J. F. Witter Teaching
and Research Center. Approximately 250mL of blood was drawn from the jugular vein of
three 1-year-old heifers. Blood was collected in a collection bag that contained the
anticoagulant, citrate phosphate dextrose adenine (CPDA). While blood was being
collected, the bag was agitated to ensure mixing of blood with the anticoagulant.
Once the blood was collected, it was processed in a similar procedure to the first cell
collection trial. In this trial, the layer between the Ficoll and plasma layers was collected,
which is the layer that truly contained PBMC. Instead of being cultured in a 48-well
plate, the cells were now cultured in 6 different 75cm2 Cell Culture Flasks. In this trial,
the seeding density was measured, using the previously described cell counting
technique. 20µL of blood was mixed with 380µL of glacial acetic acid. 10µL of this
solution was placed onto each side of a hemocytometer and the number of cells in the
central grids was counted, then averaged. See the results for the number of WBC. The
flasks were visualized using an Olympus CKX41 inverted light microscope.
The next few techniques were completed to prepare for using the IL10 ELISA.
One colony of C. psTB was collected from a plate culture using a sterile stab, and was
used to inoculate a 5mL glass tube of Brain Heart Infusion (BHI) broth. In addition, gram
stains were performed on the culture to ensure that only C. psTB was collected. A single
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colony was collected using a sterile stab and was heat-killed over a flame and placed on a
microscope slide. On a second slide, bacteria collected on a stab that ran over an area of
confluent growth were also prepared. Crystal violet stain was added for 1 minute and
rinsed off with tap water. Gram’s iodine was added for 1 minute, and was removed by
tipping the slide. The bacteria was decolorized with ethanol for a few seconds, and then
rinsed with tap water. Safranin was added for 1 minute, and rinsed with tap water. The
slides were allowed to fully dry before being inspected under a light microscope.
The method to heat-kill C. psTB was determined next. A new BHI broth culture was
set up in a 50mL centrifuge tube in the same way as before using the plate C. psTB
ATCC 19410FD. Ten labeled 1.5mL cryogenic tubes were inoculated with a single
colony from the plate. There were five treatments: treatment 1 was incubated at room
temperature (control); treatment 2 was 70°C for 5 minutes; treatment 3 was 70°C for 10
minutes; treatment 4 was 100°C for 5 minute; treatment 5 was 100°C for 10 minute. Each
treatment was completed in duplicate. The bacteria from these vials were placed on a
blood agar plate and incubated at 37°C for 48 hours, and the results were recorded.
Blood was collected again from a heifer at Witter Farm, and processed in the same
manner as before. One sample was incubated in a 75cm2 flask, and the second sample
was incubated in a 48-well plate. The cells were counted to obtain an amount of cells/mL
of blood. See the results for this information. The cells were visualized 1 week later.
Using Corning’s “Surface Areas and Recommended Media Volumes for Corning Cell
Culture Vessels”, the correct density was determined to be around 106 cells/cm2. The
density of the flask and wells were determined (see results).
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To urge the monocytes in the wells to differentiate, the density was reduced by
replating the monocytes in another well. The chosen wells were scraped using a pipette
tip, and 20µL of scraped cells were placed into a well of a 24-well plate that contained
2980µL of supplemented RPMI.
Again, bovine blood was collected at Witter Farm, and the seeding density was
determined for a 24-well plate. These macrophages were used for the first IL10 ELISA
trial. The first ELISA trial consisted of challenging macrophages for the same amount of
time with three different C. psTB antigens. The first antigen was live C. psTB. To prepare
this, a suspension was created in 6mL of RPMI by adding colonies of C. psTB until the
spectrophotometer read 80% transmittance at 590nm. One mL each of this solution was
placed into two 1.5mL centrifuge tubes.
At the same time, a mini experiment to determine how many colony forming units
(CFU) were in 1mL of the suspension was taking place. Ten µL of the suspension was
pipetted into 990µL of BHI and plated. This made a 1:100 dilution. Ten µL of the 1:100
dilution were pipetted into 990µL BHI to create a 1:10,000 dilution. Finally, 10µL of that
were placed into 990µL of BHI to create a 1:100,00 dilution. Ten µL of the 1:100,000
dilution was plated out onto three Blood Agar Plates, and one plate had 10µL of the
1:10,000 dilution on it. The results of this mini experiment are located in the results
section.
The second antigen prepared was C. psTB toxin. Five µL of concentrated C. psTB
toxin was added to 95µL of RPMI. Ten µL of that was added to 990µL of RPMI two
times to create dilutions of 1:20, and two tubes that contained a 1:2,000 dilution. These
two tubes were used in the trial. The third antigen is the heat-killed C. psTB. The vials
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from the heat treatment experiment were stored in a -80°C freezer, and were retrieved for
this preparation. The cells were thawed at room temperature, centrifuged, and the media
was aspirated and replaced with supplemented RPMI.
To prepare the macrophages, the wells that would be tested had the media aspirated
out, and replaced with RPMI with FBS without penicillin or streptomycin. Wells A1 and
A2 were challenged with 1mL of live C. psTB in RPMI at an 80% transmittance; B1 and
B2 were challenged with 1mL of dead C. psTB in RPMI at 81% transmittance; C1 and
C2 were challenged with 1mL of 1:2,000 C. psTB toxin in RPMI; D1 and D2 was the
control, and the media was replaced with RPMI with FBS and no penicillin or
streptomycin. The wells were incubated for 2 hours at 37°C in 5% CO2. After the
incubation period, 0.5mL of supernatant was aliquoted from each treated well into a
1.5mL centrifuge tube, and stored at 4°C overnight. The cells were placed back in the
incubator.
The first ELISA trial was run using the Bovine IL10 Assay Kit (#BI0030, 96 tests
from NeoBioLabs, Park Woburn, MA) per kit instructions. A wash solution was created
by adding 3mL of 100x wash to 297mL of sterile Deionized water at room temperature.
The 50µL samples were placed in 0.2 mL PCR tubes in duplicate. As a control, 50µL of
the media was placed in a tube and 50µL of A2 at 15 hours after incubation was added.
Then 5µL of balance solution was added to each sample and 50µL of samples and
standards were placed in 32 wells on the plate (see map in results). The assay was
incubated covered at room temperature for 1 hour. One hundred µL of conjugate solution
was added to each well and it was incubated for another hour in a 37°C incubator. Wells
were washed five times with the kit-provided wash solution, and 50µL of solution A was
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added, followed by 50µL of solution B. The assay was incubated for another 30 minutes,
and 50µL of STOP was added. The plate was read by a plate reader at 450nm.
For the second IL10 ELISA, blood was collected from Icelandic Ewes at Witter
Farm. The blood was processed and macrophages were isolated. The second IL10 ELISA
trial tested macrophages challenged with live C. psTB with samples taken at different
time points. The solution of live C. psTB was created as before, and macrophages were
challenged with the bacteria for 1 hour. After the wells had RPMI with penicillin and
streptomycin placed in them, they were incubated for another hour. At 1 hour, a sample
was taken from the four wells (2 challenge wells and 2 control wells). Samples were also
taken at time 2, 4, 6, 12, and 24 hours. The ELISA assay was run using these 24 samples
in duplicate.
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RESULTS AND DISCUSSION

The first trial of processing blood collected from sheep at a farm in Maine was
unsuccessful for a few reasons. First, the centrifugation used was too aggressive, and
made it impossible to recover cells. Second, the layer that was pulled off when the
sample was processed with Ficoll Paque was the layer that contained granulocytes, not
PBMC. The figure below shows the layers that the sample separates into after
centrifugation.

Fig. 1: Ficoll paque layers after centrifugation. The peripheral blood mononuclear cell
(PBMC) layer contains the monocytes. The bottom layer (RBCs) is a red blood cell pellet
(Photo: nature.com).
When the viability was tested for the four samples, no viable cells were seen. Sample
1 and 2 contained no cells, sample 3 contained 1 non-viable cell, and sample 4 had no
cells in the grid area.
The next blood draws were completed on bovine subjects rather than ovine subjects
because the researchers did not have access to ovine subjects at that time. Caseous
lymphadenitis is a disease that can also affect cattle, so the immune systems of the two
animals are similar. In the first cell counting trial that was completed, 37 cells were
15

counted in the grid; adjusted by the dilution factors of 104 and 20, the final concentration
was 7.4 cells/mL blood. To find the seeding densities of the 6 flasks, the original volume
of blood that was used to create the sample in the flask was divided by the amount of
RPMI and multiplied by the cell/mL. See the table below for the seeding densities of the
6 flasks.
Table 1: Seeding densities of 6 flasks in trial 2 of processing macrophages.
Flask Number
1
2
3
4
5
6

Original
Volume of
Blood (mL)
****
33
33
50
50
50

Volume of
RPMI (mL)

Cell/mL

****
30
30
30
30
15

7.4x106
7.4x106
7.4x106
7.4x106
7.4x106
7.4x106

Seeding
Density
(cells/mL)
****
8.14x106
8.14x106
1.23x107
1.23x107
2.47x107

From a visual check, flask 6 has the most differentiation. Below is a picture of flask 6
taken 14 days after incubation began.

Fig. 2: Flask 6 - Differentiating monocytes at day 14 of incubation (Photo: Ann
Bryant).
16

Below is a table that describes the results of the heat-kill trial. Although not included
in this table, sterile BHI (without C. psTB; control) showed no growth.
Table 2: C. psTB growth results of heat-kill trial.
Treatment Number

Sample 1

1: Incubated at room temp
2: 70°C for 5 min
3: 70°C for 10 min
4: 100°C for 5 min
5: 100°C for 10 min

Good Growth - Lawn
No Growth
No Growth
No Growth
No Growth

Sample 2 (Duplicate of
Sample 1)
Good Growth – Lawn
No Growth
No Growth
No Growth
No Growth

For the third macrophage processing trial, the samples were placed in a 48-well plate
and a 75cm2 flask. Each well contained an original volume of 3.47mL of whole blood.
The cell count was 64 cells in the grid, which was equivalent to 1.066x107 cells/well. In
the flask, the cell count was 36, equivalent to 1.08x108 cells/flask. The total number of
cells/cm2 was 1.12x107 cells/cm2. In the cell culture flask there were 1.44x106 cells/cm2.
The recommendation from Corning is that cell culture surfaces be seeded at a density
of 106 cells/cm2. For this reason, the cells in the flask differentiated well, but the cells in
the wells were too crowded. Below are pictures of the well and the flask.

Fig. 3: Macrophages in well at 40x magnification. The seeding density is too high for the
monocytes to differentiate into macrophages (Photo: Ann Bryant).
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Fig. 4: Macrophages in Flask at 20x magnification. Differentiated macrophages. The
seeding density was low enough so that there was space between the cells so the
monocytes could differentiate (Photo: Ann Bryant).
Because of the high density in the wells, the decision was made to replate the cells in
new wells to decrease the cell density in the old well, and also place a correct cell density
in new wells. The cell density was determined in two of the original wells, A1 and B1.
The cell density in A1 was 1.30x106 cells/mL, and the cell density in B1 is 1.33x 106
cells/mL. When 20µL was taken from each well and placed in a new well, the seeding
density was 3.25x105.
In the next processing of macrophages, the cell densities were determined to be
1.0x107 cells/mL. To make 2 plates, 12mL of sample was used on each plate. 1.0x107
cells/mL x 12mL = 1.2x108 cells total / 24 wells = 5x106 cells/well
5x106 cells/well / 1.9cm2/well = 2.6x106 cells/cm2
The CFUs were calculated from the 4 blood agar plates, see Table 3.
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Table 3: Results of growing C. psTB on a blood agar plate
Plate Number
1
2
3
4

Dilution
1:100,000
1:100,000
1:100,000
1:10,000

Number of Colonies
5
24
3
54

The average number of colonies (1:1000 dilution) was 10.7. This was multiplied by the
dilution factor of 105 to get 1.1x106, which is the approximate number of C.psTB CFU in
10µL. That means there are approximately 1.1x108 CFU /mL.
The standard curve for the first ELISA trial is shown below in Figure 5.

Fig. 5: Standard curve for ELISA Trial 1 (points are mean ± SD). The graph shows the
absorbance of the kit standards, which contained 50, 100, 250, 500, and 1000 pg/mL of
IL-10. The error bars show the standard deviation between the duplicate samples. The R2
value is relatively low for this curve, meaning that the points do not fall close to the line
of best fit. This error was attributed to procedural error in the technique.
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Figure 6 shows the data that was collected from the first ELISA trial.

Fig. 6: Absorbance of IL10 for macrophages challenged with different antigens. The
error bars represent the standard deviation between the duplicate samples.
In the second ELISA trial, the standard curve appeared linear, with smaller standard
deviations, see Figure 7. The samples produced very little IL10, see Figure 8.

Fig. 7: Standard Curve for ELISA trial 2. The graph shows the absorbance of the kit
standards. The standards were 50, 100, 250, 500, and 1000 pg/mL of IL-10. The error
bars show the standard deviation between the duplicate samples.
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Fig. 8: Absorbance at each tested time point. A2 and A3 represents wells that were
challenged with live C. psTB, and B3 and C1 represent the control wells. The error bars
show the standard deviation between the duplicate samples.
If Figures 7 and 8 are compared, the absorbance of the highest point in Trial 2 is
about 1/10 of the smallest standard value, which is 50pg/mL. This means that the highest
amount of IL10 produced was about 5pg/mL, which is a very small value. The standard
deviation of the points show that the variability within sample duplicates is greater than
that between samples, so no conclusions can be drawn about IL10 production over time.
However, the standard curve appeared to have provided acceptable results.
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CONCLUSIONS AND IMPLICATIONS

Throughout the process, many techniques were successful, including the macrophage
culturing, cell counting, cell freezing, and the heat-kill treatment of C. psTB. No
significant amount of IL10 was produced in either ELISA test. In the first ELISA trial,
the standard curve was not linear. The R-squared value associated with the line of best fit
is 0.93; a value closer to 1 would be desireable. Because this was the first time we used
this IL10 kit, we had not optimized our use of the procedure. The experimental results
revealed very little, if any, IL10 production. The duplicate samples were highly variable,
suggesting that the IL10 levels detected may have occurred by chance.
The second ELISA trial had a more linear standard curve, showing the improved
technique between the two trials. Again, there is no pattern between the time points of a
sample, and the amount of IL10 measured is very low.
There are many variables that deserve exploration to optimize technique for
investigating the question. We may have selected inadequate levels of antigen to
stimulate the macrophages, or have use inadequate time for stimulation of the
macrophages. If the antigen was in for too long, it could have killed the macrophages,
and if the antigen was not in long enough, IL10 production might have been inadequately
stimulated. Another source of error could have been in the time chosen to take samples. If
IL10 was produced in the first half an hour, and then broke down in solution, the intervals
would have all been too long. However, Le et al. (1997) concluded that the half-life for
IL10 mRNA was 60 minutes.26 In this situation, there should have been a peak in IL10
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production, and then the level should have dropped in a linear fashion over time until it
reached the basal production level. However, our the data did not display this pattern.
This project began some of the necessary background research for future
investigations of resistance to CL in sheep. Some basic information was gained about the
release of IL10 from macrophages challenged with CL antigens, including live C. psTB,
heat-killed C. psTB, and C. psTB toxin. The trials that were completed did not show any
significant amount of IL10 release, so future work may involve utilizing different
conditions to enhance IL10 production. Future projects could also include investigating
different cytokines (IL8, in particular), and examining conditions that will produce
measurable amounts of IL10. Investigating possible genetic markers for susceptibility or
resistance to CL is another area for possible study. This work established useful standard
operating procedures for cell culture and cytokine measurement, and served as a
preliminary investigation of IL10’s role in the pathophysiology of CL.
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APPENDIX A

Monocyte isolation from whole blood standard operating procedure (SOP).

Prepared by: Amy Fish

Date: 7/8/14

Reviewed by: Anne Lichtenwalner Date: 7/12/2014
Approved by: Anne Lichtenwalner Date: 10/06/2014
The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
To remove contaminants from mammalian mononuclear blood cells to prepare
them for use in cell cultures.
Hazards:
1. Exposure to penicillin and streptomycin for allergic personnel: wearing safety
glasses, a mask, gloves and labcoat is recommended when working with this
substance. Working in groups of at least 2 people is required.
2. Exposure to zoonotic pathogens from small ruminants
3. Wear proper PPE for all lab work.
Specimen:
Blood samples from sheep, cattle or goats.
Material Required:
• Pipettors (1 and 25 ml) and sterile tips
• Motorized pipettor with 200 µl and 1 mL sterile pipets
• Sterile Disposable 3ml Pasteur Pipette
• Sharps container for tips disposal
• 10 to 250 mL blood sample properly collected and stored in a collection tube
containing EDTA or heparin, under refrigeration. No more than 24 hours old.
• Per 50 ml tube of sample, 50-100 mL of sterile Hank’s Balanced Salt Solution
(HBSS) at room temperature (SH3001602)
• Sterile 50 ml and 15 ml tubes with tops (05-539-6) (Labnet: KD-8881-301710)
• Tube racks for 50 and 15 ml tubes
• Per sample, at least 10 mL sterile Ficoll-Paque solution at room temperature (45001-751)
• Non-chilled centrifuge capable of 300xg and 900xg. Brake off
• At least 100 mL per flask or well-plate of RPMI-1640 w/ L-glutamine at room
temperature (SH3002701)
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•
•

•

10% Heat inactivated Fetal Bovine Serum at room temperature (SH3091002HI);
at least 5 ml per 50 ml RPMI (see chart below)
At least 1 mL/assay of Penicillin/Streptomycin mixture at room
temperature(BP295950) (1000 U/mL Penicillin and 10 mg/mL Streptomycin) (see
chart below)
Cell-culture type plate: 24 to 96 well plate; Corning (size dependent on assay
being run)

Procedure:
1. Create a 1:2 mixture of whole blood to HBSS in a sterile flask.
2. Mix gently together by swirling.
3. Using a pipette, place 10 ml Ficoll-Paque into a new 50 mL centrifuge tube.
4. Critical step: Gently pipette (layer) 25 ml of the 1:2 mixture of blood and HBSS
on top of the Ficoll-Paque. Do not allow blood mixture to dispense into FicollPaque.
NOTE: If blood is pipetted onto the Ficoll-Paque and allowed to sit for more than
approximately 10 minutes, the interface will break down, and blood will mix into
Ficoll-Paque layer.
5. Turn off the brake completely (set to 0) prior to running centrifuge. Centrifuge
the tube at 900xg for 30 minutes at room temp. Be sure to carefully check the
balance to avoid vibrations. Transfer the tubes gently to the working area; avoid
disruption of the layers.
6. Carefully, using a sterile Pasteur pipette, remove the layer of mononuclear cells
from the HBSS-Ficoll-Paque interface. This step may be done within a cell
culture hood. Place half the cells into one labeled 50 ml centrifuge tube containing
15 ml HBSS, and place the remaining half into another labeled 50 ml tube.
NOTE: The PBMC’s are located between the top two layers. The serum is the
orange layer on top, the Ficoll is the cloudy layer below that. There is a very thin
clear layer with visible cells between the two. Pipette off the cells.
7. Repeat step 3-6 twice more for a total of 3 times.
8. Centrifuge the two tubes 300xg for 10 minutes with the brake turned off, then
pipette off supernatant.
9. Add 25 ml HBSS to rinse the cells. Draw cells into solution with a Pasteur
pipette.
10. Repeat step 7-9 for a total of three rinses. After centrifuging the third time, do not
add HBSS, move onto step 10.
11. Create the supplement RPMI-1640 by adding 10% heat inactivated fetal bovine
serum and the penicillin/streptomycin mixture (see Table 2 for proportions).
12. Resuspend the washed cells after HBSS removed, using 10 mL of the
supplemented RPMI-1640. Invert gently to mix.
13. Count cell density using a hemocytometer. Adjust density to 1x105 cells/mL using
RPMI.
14. Divide the solution equally into each well of a 24-well plate.
15. Bring the volume in the well up to 2.5 ml by adding in the necessary
supplemented RPMI.
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16. Incubate the flasks for 24 hours at 37° C in 5% CO2 in H262; check cells using
inverted scope.
17. Remove non-adherent cells by washing twice with room temperature HBSS. To
do this, using sterile technique, pipette out the media without touching the bottom
of the well from each of the 24 wells. Replace with 1 ml of HBSS in each well,
gently rock them for 2 minutes. Aspirate out most of the fluid without touching
the bottom of the well. Discard this fluid. Repeat this twice more for a total of
three HBSS washes. Replace each well with 2.5 ml of RPMI/FBS/PenStrep per
flask (see chart below). Rock plate gently again, and replace into incubator.
18. Incubate the adherent cells for 7-14 days at 37 C in supplemented RPMI-1640,
which will allow monocytes to differentiate into macrophages.
19. After 7 days of incubation, change the media.
a. Using sterile technique and working in a cell culture hood, aspirate out the
old media using sterile pipette tips. Use a 1 ml pipette tip for each well.
b. Add 2.5 ml of room temperature supplemented RPMI to each well.
c. Place plate back in the 37C 5% CO2 incubator.
Procedural Notes
Use sterile technique throughout the procedure. Work with cells in a clean cell
culture hood.
Ficoll-Paque: Turns yellow in appearance when deteriorated – Do not use. 18°C20°C is the optimal temperature for the liquid.

References:
Freshney, R. (1987). Culture of animal cells: A manual of basic technique (2nd ed.). New
York: A.R. Liss.
Revision History:

Table 1: Making RPMI Mixture
Size of Plate
Volume of RPMI Volume of
Being Used
Needed (mL)
Penicillin/Streptomycin
Mixture Needed (mL)
50 ml centrifuge 45
.45
tube
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Volume of HeatInactivated FBS
Needed (mL)
4.5

APPENDIX B

Cell counting SOP

Prepared by: Amy Fish
Reviewed by: Ann Bryant

Date: 8/5/14
Date: 8/5/14

Approved by: Anne Lichtenwalner Date: 8/5/14
The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
This technique will allow researchers to correctly count how many viable cells are in a
particular sample, so that when the cells are placed in wells, they can be seeded in their
correct density.
Hazards:
1. Trypan blue may cause irritation if it comes in contact with skin. It is a known
carcinogen. Use impervious gloves to handle. Trypan blue is handled as a dilute
solution in this procedure to reduce risk.
2. Always wear proper PPE
Specimen:
Any type of cell solution
Material Required:
• 37°C water bath
• Supplemented RPMI (See Cell Wash SOP)
• 1ml pipette
• Sterile pipette tips
• Sterile PBS
• Hemocytometer
• Cover Slips for Hemocytometer
• 70% ethanol
• KIM wipes
• Microscope
• Sterile 96-well plate
Procedure:
1. Clean the hemocytometer and cover slip using 70% ethanol and KIM wipes

30

2. Place the coverslip onto the hemocytometer
3. Create cell stock by either thawing a sample (see cell thawing SOP) or by
preparing a cell culture as follows:
a. Aspirate the media from the well
b. Rinse the cells once with 1ml of PBS
c. Remove PBS and add 1ml of 0.05% trypsin
d. Incubate the well at 37°C and 5% CO2 until cells appear rounded and
floating. Check cells at 10, 20, and 30 minutes.
4. Add 25µl of 0.4% trypan blue solution to 212.5µl of supplemented RPMI in a
sterile 1.5 ml cryogenic snapcap tube
5. Add 12.5µl of cell stock to the trypan blue and RPMI, and gently pipet up and
down 4-5 times to mix the solution
Note: These values create a 1:20 dilution
6. Pipette out 10µl of the solution
7. Dispense the solution onto one of the V-shaped wells on the side of the
hemocytometer (with the coverslip in place)
8. Pipette another 10µl onto the second side of the hemocytometer.
9. After the hemocytometer has filled by capillary action, place the hemocytometer
on the microscope stage
10. Bring the image into focus on low power
11. Count all cells (viable and non-viable) in the 1mm center square and the 4 corner
squares
12. Keep a separate count of viable and non-viable cells
13. Use Corning’s “Surface Areas and Recommended Medium Volume for Corning
Cell Culture Vessels” to determine the seeding density of the specific cell culture
plate or flask.
Procedural Notes

References:
http://web.mnstate.edu/provost/CountingCellsHemocytometer.pdf
http://www.lipidmaps.org/protocols/PP0000000100.pdf

31

APPENDIX C

Challenging macrophages with C. psTB antigens (Trial 1) SOP

Prepared by: Amy Fish

Date: 11/17/14

Reviewed by: Ann Bryant

Date: 11/17/14

Approved by: Anne Lichtenwalner

Date: 11/17/14

The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
How to challenge macrophages with CL toxin, live Corynebacterium pseudotuberculosis,
and dead C. psTB.
Hazards:
C. psTB is a BSL 2 organism, and can cause infection in humans. Make sure that all PPE
is on and secure. Wear a face mask in addition to gloves and lab coat. Lab work must be
directly supervised by laboratory technician or lab director.
Specimen:
Cultured bovine or ovine macrophages
Material Required:
• 37°C 5% CO2 incubator
• Cultured Macrophages
• Live Corynebacterium pseudotuberculosis
• Heat killed C. pseudotuberculosis (See Heat Treatment SOP)
• C. psTB Toxin
• Hank’s balanced salt solution (HBSS)
• 1 ml pipettor with sterile tips
• 1 µl pipettor with sterile tips
• Spectrometer
• BHI broth
• Supplemented RPMI (without Pen/Strep)
• Supplemented RPMI (with Pen/Strep)
Procedure:
1. Designate how many wells will receive each treatment.
2. Draw this plan out in a lab notebook.
3. Infect macrophages with whole killed bacteria
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a. Adjust absorbance of the media plus dead cells to 40% absorbance (this
will equate to a 106 cell/ml density) by adding BHI broth if necessary.
b. Spin the cells down at 900xg for 10 minutes to create a pellet.
c. Aspirate all of the BHI broth out of the microtube.
d. Add in the same volume of Supplemented RPMI (see cell washing SOP)
to replace the aspirated BHI.
e. Ensure that the cells are mixed back into the RPMI by using the
spectrometer.
f. Aspirate out the 2ml of media in the wells that will be challenged.
g. Add 1ml of the bacteria/RPMI mixture to each of the wells of
macrophages designated to be challenged by killed bacteria.
4. Infect macrophages with live bacteria.
a. Repeat steps a-f from above.
b. Add 1ml of the bacteria/RPMI mixture to each well designated to be
challenged by live bacteria.
5. Infect macrophages with C. psTB toxin.
a. Dilute the toxin in a 1:2000 dilution.
b. 1µl of toxin into 2000µl of supplemented RPMI
c. Aspirate out the 2 ml of supplemented RPMI present in each well that will
be challenged.
d. Pipette 1 ml of toxin/RPMI mix into each well designated to be challenged
with C. psTB toxin.
6. Place the plate back in the incubator for 1 hour.
7. Asprirate out the challenging media from each well.
8. Pipette in 1 ml of supplemented RPMI (with pen/strep)
9. Incubate plate for another 1 hour.
10. Draw out 110µl from each well and place in a labeled snapcap vial.
11. Run the ELISA using these samples and the kit standards.
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APPENDIX D

Challenging macrophages with live C. psTB (Trial 2) SOP

Prepared by: Amy Fish

Date: 12/9/14

Reviewed by: Ann Bryant

Date: 12/9/14

Approved by: Anne Lichtenwalner

Date: 12/9/14

The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
Challenge macrophages with live Corynebacterium pseudotuberculosis.
Hazards:
C. psTB is a BSL 2 organism, and can cause infection in humans. Make sure that all PPE
is on and secure. Wear a face mask in addition to gloves and lab coat. All work in the lab
must be done under the direct supervision of the lab technician or lab director.
Specimen:
Cultured bovine or ovine macrophages
Material Required:
• 37°C 5% CO2 incubator
• Cultured Macrophages, 14 days old
• Live Corynebacterium pseudotuberculosis culture (from pure plated culture), 4 days
old
• Hank’s balanced salt solution (HBSS) (37C)
• 1 ml pipettor with sterile tips
• 10 µl pipettor with sterile tips
• Spectrophotometer (Spec 20, Bausch and Lomb)
• Sterile BHI broth
• Supplemented sterile RPMI (without Pen/Strep) (37C)
• Supplemented sterile RPMI (with Pen/Strep) (37C)
• Sterile loops
• 1.5 ml sterile cryogenic snapcap
• IL-10 ELISA kit
Procedure:
12. Prepare C. pseudotuberculosis broth
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a. Using a sterile loop, pick about 3 single colonies from the C.
pseudotuberculosis culture plate.
b. Stir the loop into a sterile glass tube with 6ml of RPMI with no Pen/Strep
c. Check that the tube has 80% transmittance in the spectrophotometer, with
RPMI as a blank.
i. If not, adjust by adding more bacteria or RPMI as necessary.
d. Place 1 ml of the 80% solution into a 1.5ml cryogenic snapcap tube
e. Pipette out 10µl of the 80% solution into 990µl of BHI (creating a 1:100
dilution).
f. Dilute again by taking 10µl of the 1:100 dilution and placing it into 990µl
of BHI (resulting in a 1:10,000 dilution). This is the working stock.
i. Spread 10µl of the working stock onto 3 blood agar plates to
determine how many CFUs are in the working stock.
ii. Incubate the plates at 37C for 3 days.
iii. Count the CFUs and average the three plate values together.
13. Choose the macrophages by visually picking two wells that have approximately
the same density, and by completing cell counts on each using the Cell Counting
SOP. This will define average cell density.
14. Assign treatments and map out which two wells will be used for bacteria, and
which two will be used as the “cells in media” control.
15. Infect macrophages with live bacteria.
a. Aspirate out all of the RPMI w/ Pen/strep (should be 2ml) from each well
needed
b. Add 3 ml of C. pseudotuberculosis working stock.
16. Incubate the cells for 1 hour at 37C in H240.
17. Remove the C. pseudotuberculosis media from each well, and replace with
RPMI w/ pen/strep
18. Replace in the incubator for 1 hour
19. Draw out 110µl from each well (both C. pseudo wells and both cell and media
control wells) and place in a labeled snapcap vial.
20. Replace in the incubator.
21. Repeat steps 8-10 at hour 2 (after media change), hour 4, 6, 11, and 21.
22. Run the ELISA using all 48 samples (plus the 14 standards).
Procedural Notes
** This will use up the remaining ELISA wells, and we will need to buy another
before we can test anything else. We believe it is necessary to collect data from so
many time points because we need to know how long after infection IL-10
production is at it’s highest. These data points should give us a nice curve of IL-10
production.
**Because of collecting so many time points, we have decided to only focus on the
live C. pseudotuberculosis bacteria. Otherwise, we would have changed too many
variables at one time.
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APPENDIX E
Heat kill C. psTB SOP

Prepared by: Amy Fish

Date: 9/6/14

Reviewed by: Ann Bryant

Date: 9/6/14

Approved by: Anne Lichtenwalner Date: 9/6/14
The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
This technique will inform preparing C. psTB antigen for cell stimulation.
Hazards:
3. Use caution, including PPE and working in BSL2 conditions (BSC), when
handling C. psTB
4. Always wear proper PPE
5. All work in the lab must be done under the direct supervision of the lab technician
or lab director.
Specimen:
48 hour cultures of C. psTB (ATCC strain)
Material Required:
• Sterile BHI in sterile 50 ml tubes (40 ml culture)
• Inoculating loop/stab: sterile
• 48 hour old C. psTB culture on BAP
• BSC
• 2 heat blocks placed in BSC on blue mats; set to 70 and 100 C
• 1ml pipette
• Sterile pipette tips
• Sterile PBS
• 70% ethanol
• KIM wipes
• Microscope
• Spectrophotometer and cuvettes
• 1.5 ml sterile snapcap tubes; ~30
• Timer
• Ice bath
Procedure:
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14. Day 0: pick 1 colony from the 48 hour culture, inoculate each of the BHI tube
with a group of colonies picked up by sterile loop. Grow in CO2 incubator at 37C
15. Day 2: Place heat blocks in BSC, set temp. Turn on spec. Label 1.5 ml tubes
(cultures A or B, txt 1-5: 1 is RT control, 2 is 70 for 5 min, 3 is 70 for 10, 4 is 100
for 5 min, 5 is 100 for 10 min).
16. Pipette 1 ml of each culture into the appropriate tubes
a. Incubate each tube in the appropriate heat block for the appropriate time.
Immediately remove into ice when finished.
17. Using 5 ml of culture, use Spec 20 to read T at 590 nm. Record.
18. Split 5 BAP, label as 1-5, then label ½ A and ½ B of each plate. Streak each
snapcap vial’s contents onto a ½ plate using sterile technique.
19. Culture for 48 hours at 37C in CO2 and check for growth.
Procedural Notes

References:
http://web.mnstate.edu/provost/CountingCellsHemocytometer.pdf
http://www.lipidmaps.org/protocols/PP0000000100.pdf
http://triangleresearchlabs.net/wp-content/uploads/downloads/2013/01/TrypanBlue-Cell-Counting-Protocol.pdf
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APPENDIX F

Replating macrophages SOP

Prepared by: Amy Fish

Date: 10/6/14

Reviewed by: Ann Bryant

Date: 10/6/14

Approved by: Anne Lichtenwalner Date: 10/6/14
The colored ink stamp indicates this is a controlled document. Absence of color
indicates this copy is not controlled and will not receive revision updates.
Purpose:
To remove differentiated macrophages and calculate viability and concentration.
Hazards:
1. Exposure to penicillin and streptomycin for allergic personnel: wearing safety
glasses, a mask, gloves and labcoat is recommended when working with this
substance. Working in groups of at least 2 people is required.
2. Trypan blue may cause irritation if it comes in contact with skin. It is a known
carcinogen. Use impervious gloves to handle and wear eye protection.
3. Always wear proper PPE.
4. All work in the lab must be done under the direct supervision of the lab technician
or lab director.
Specimen:
• Ovine or bovine macrophages cultured in a flask or 48-well plate
Material Required:
• 75 ml per each 24-well plate of RPMI-1640 w/ L-glutamine (SH3002701)
supplemented with 10% Heat Inactivated Fetal Bovine Serum (SH3091002HI)
and Penicillin/Streptomycin (BP295950) (1000 U/mL Penicillin and 10 mg/mL
Streptomycin) (See Cell Wash SOP for instructions on making RPMI)
• 24-well Corning plate
• Hank’s Balanced Salt Solution (HBSS) (SH3001602)
• Motorized pipettor
• 25ml sterile pipette tips
• Inverted Microscope
• 1 ml pipettor and sterile tips
• 37C 5% CO2 Incubator
Procedure:
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Prepare the 24-well Plate
1. Pipette 2 ml of supplemented RPMI (see Cell Wash SOP) into each of the 24
wells
Removal Step- 48-well
1. Using a sterile 1 ml pipette tip, scrape the bottom and sides of the well to remove
adherent macrophages
2. Complete a cell count on the well to assess viability
3. Using a sterile small pipette tip and a 200µl pipettor, pipet 40µl out of the well,
and pipet the cells and media into each well on the 24-well plate.
4. Add 2.9 ml of supplemented RPMI into each well.
5. Check adherence under inverted scope.
6. Place cells in 37C 5% CO2 incubator.
Procedural Notes
Some work done in H262; shared BSL2 compatible lab.
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